Conclusion: Eosinophil aggregates on histopathology are significantly more likely to be present in recurrent CRSwNP. In the limited series, tissue eosinophilia (>10 per HPF) was not significantly different in primary and recurrent CRSwNP. Therefore, in addition to the study of tissue eosinophilia levels, Rhinologic surgeons should also direct attention to CRSwNP mucin. Mucin eosinophilic aggregates are an independent marker of severe inflammation that is associated more likely with recurrent vs
primary polyposis. Further study of this marker may help determine its role of choice of postoperative medical therapies, including anti-eosinophilic biologics.
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| INTRODUCTION
Chronic rhinosinusitis with nasal polyposis (CRSwNP) is one of the two major phenotypes of chronic rhinosinusitis (CRS) and is defined by the presence of nasal polyps in the middle meatus. 1 Studies have
shown that CRSwNP negatively affects quality of life and is a common problem worldwide, with prevalence estimates of 0.2%-4%. 2, 3 While surgery provides significant benefit in symptomatology and respiratory health, 4, 5 as many as 40% of the patients with CRSwNP may develop recurrent polyposis within 12 months postoperatively. 6, 7 Clinical factors such as asthma prevalence, as well as aspirinexacerbated respiratory disease (AERD), appear to be associated with higher recurrence rates of nasal polyps. 6, 7 CRSwNP that is recalcitrant to medical and surgical therapies may impact asthma control. [8] [9] [10] There has been increasing interest in studying histopathology and serum inflammatory mediators to identify endotypic and prognosticating features in CRS. Standardized reporting using a structured histopathologic analysis of 13 predefined parameters has been recently described for CRS. 11 Histopathologic features, such as inflammatory cell predominance, subepithelial edema, Charcot-Leyden crystals, and mucin eosinophil aggregates, have been investigated as potential differentiating factors in patients with CRSwNP vs chronic rhinosinusitis without nasal polyposis (CRSsNP). vs 25%). 13 To our knowledge, no study has investigated differences in primary vs recurrent nasal polyps in CRSwNP using the standardized, structured histopathology report. The current study investigates tissue removed during surgery for primary vs recurrent nasal polyps in CRSwNP patients. In addition to structured histopathology, clinical characteristics of patients undergoing surgery for primary vs recurrent CRSwNP were also analyzed.
| MATERIALS AND METHODS
The study was approved by the institutional review board of the Table 2 .
Eosinophil aggregates were more common in recurrent CRSwNP mucin (57.9%, n = 33) compared to primary CRSwNP tissue (35.9%, n = 14), and this difference was statistically significant (P = .034).
Other parameters were not statistically different between the two groups. Not all patients with eosinophilic predominance were found to have eosinophil aggregates. Conversely, some patients with other types of inflammatory predominance did have eosinophil aggregates present. Overall patients with eosinophilic predominance were more likely to have eosinophil aggregates (P < .001), although patients with both eosinophilic predominance and eosinophil aggregates were not different between primary and recurrent nasal polyps (P = .923).
T A B L E 2 Primary vs revision surgery according to structured histopathology
Patient demographics, preoperative SNOT-22, and Lund-Mackay CT scores are detailed in Table 3 . There were no statistical differences in age (P = .861), gender (P = .907), preoperative SNOT-22 score (P = .367), Lund-Mackay CT score (P = .182), and AFRS diagnosis (P = .403) between the two cohorts. Patients in the revision group had a higher prevalence of asthma (n = 42, 73.7%) compared to those who underwent primary surgery (n = 20, 51.2%). While this difference was statistically significant (P = .042) on univariate analysis, it regressed on multivariable logistic analysis (P = .103). Diagnosis of AERD was also significantly higher (P = .005) in recurrent CRSwNP (n = 22, 38.6%) compared to primary disease (n = 4, 10.3%), and multivariable logistic regression analysis found AERD to be statistically significant (P = .008). Eosinophil aggregates were associated with recurrent nasal polyps on multivariable logistic regression analysis (P = .047), when accounting for AERD and asthma.
| DISCUSSION
Most published studies have focused on using histopathologic markers to assess the general features of CRS or differentiate between CRSwNP and CRSsNP. [11] [12] [13] [15] [16] [17] [18] Various studies investigating histopathologic markers in CRSwNP have identified the presence of eosinophilia as an important factor. [11] [12] [13] [15] [16] [17] [18] Moreover, eosinophilia has been suggested as a marker for worse decrease in smell, 15 disease severity, 16 and recurrence. 17 One study comparing risk of polyp recurrence used a volume-based analysis of tissue eosinophilia. 13 Typically this has been subdivided into local tissue eosinophilia 11,13,18 and eosinophil aggregates, 11, 12 which may be a sign of eosinophilic activity.
Structured histopathology evaluation of CRS is a relatively new
endeavor that aims to capture and report on 13 inflammatory characteristics of sinonasal tissue and mucin removed during ESS. 11 Prognostic implications of this report have yet to be comprehensively established. To our knowledge, this is the first study to investigate histopathologic differences in primary and recurrent CRSwNP tissue using the detailed structured report format. We found that eosinophil aggregates were more common in recurrent nasal polyp mucin but did not find differences in tissue eosinophilia levels between primary and recurrent CRSwNP tissue using a threshold value of 10 eosinophils per HPF. 18 There were no statistical differences in the detected amount of fungal elements between both groups. This report suggests that eosinophilic aggregates in the mucin, which are hallmarks of hyperactive eosinophilic inflammation, are an important consideration that needs to be further evaluated.
Eosinophilic aggregates have been reported in patients with
CRSwNP in only three prior studies. 11, 12, 19 A study conducted by Kuhar et al. posited that the presence of tissue eosinophilic aggregates may be a useful predictor of polyposis and may also indicate a more severe disease process. 12 The current study finds that eosinophil aggregates are more prevalent in recurrent CRSwNP mucin compared to primary disease. This further supports previous studies'
findings that activated eosinophils may play role in more severe (recurrent) CRSwNP and indicate disease that is difficult to treat with standard therapies. A recent study also suggests that tissue eosinophil aggregates were the most substantial driving factor for increased cumulative prednisone doses following sinus surgery. 19 In this study, patients with eosinophilic predominance were more likely to have eosinophil aggregates (P < .001), although patients with both eosinophilic predominance and eosinophil aggregates were not different between primary and recurrent nasal polyp tissue.
The presence of local tissue eosinophilia in primary and recurrent CRSwNP has been studied more extensively than eosinophilic aggregates. 11, 13, 18 For example, a study conducted by Bassiouni et al. in 2015 evaluated local tissue eosinophilia in patients who had recurrent CRSwNP compared to those who did not require revision surgery.
That study found that increased local eosinophilia (≥10 per HPF)
T A B L E 3 Demographic and baseline characteristics of study population correlated with higher rates of recurrence and increased likelihood of requirement for further ESS. 18 Our study did not find a difference between primary and recurrent CRSwNP when evaluating local tissue eosinophilia. This suggests that investigating higher thresholds for tis- 
| CONCLUSION
Eosinophil aggregates on histopathology are significantly more likely to be present in recurrent CRSwNP mucin. We did not identify any other differences in recurrent vs primary CRSwNP tissue on the 13-item structured histopathology report. In this limited series, tissue eosinophilia (10 per HPF threshold) was not significantly different in primary and recurrent CRSwNP. The presence of eosinophilic aggregates in the mucin may mark eosinophilic activity and potentially more severe disease. Therefore, in addition to the attention devoted to tissue eosinophilia, rhinologic surgeons should also direct attention to sampling mucin in CRSwNP. Mucin eosinophilic aggregates may be an independent marker of severe inflammation that is more likely to be associated with recurrent versus primary CRSwNP.
